RGC
Regencell BioscienceCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RGC vs peer average
40/100
RGC vs. peer average (C vs. B)
Grade spread
A 3 · B 3 · C 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALKS is the first available peer comparator.
Mid-cap biotech with mixed commercial and R&D exposures; helpful as a reference for re-rating tied to commercial proofs.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RGC
Regencell Bioscience
ALKS
Alkermes
Grade
C
A
Momentum
28
84
Value
41
65
Sentiment
84
54
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ALKS
RGC / ALKS
Grade Position
Below peers
RGC vs. peer average (C vs. B)
40/100
Momentum
28
ALKSValue
41
ALKSSentiment
84
RGCRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RGC
ALKS is the first peer returned for this comparison set.